AMOEBA (EPA:ALMIB) | WebDisclosure

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Home
Companies
AMOEBA

BRIEF

published on 10/29/2025 at 08:05, 1 month 6 days ago

Amoéba : Bilan Positif des Essais Viticoles 2025

AXPERA Réduction Cuivre Mildiou Essais Viticoles Commercialisation 2026
BRIEF

published on 10/29/2025 at 08:05, 1 month 6 days ago

Amoéba: Positive Results of the 2025 Vine Trials

AXPERA Copper Reduction Viticultural Trials Mildew Commercialization 2026
PRESS RELEASE

published on 10/29/2025 at 08:00, 1 month 6 days ago

Amoéba presents the 2025 results of its vineyard trial campaign: AXPERA confirms its effectiveness against downy mildew and its strong potential to significantly reduce copper use
Amoéba presents 2025 vineyard trial results confirming AXPERA's efficacy against downy mildew. AXPERA's performance in real conditions and response to French regulatory framework highlighted. Market authorization process and commercial launch details shared

AMOEBA Regulatory Framework Market Authorization AXPERA Vineyard Trial
PRESS RELEASE

published on 10/29/2025 at 08:00, 1 month 6 days ago

Amoéba présente le bilan 2025 de sa campagne d'essais viticoles : AXPERA confirme son efficacité contre le mildiou et sa capacité à réduire fortement l'usage du cuivre
Amoéba présente les résultats des essais viticoles 2025 pour AXPERA, confirmant son efficacité contre le mildiou. Cadre réglementaire durci en France, démarches d'homologation en cours pour commercialisation en 2026

AMOEBA Homologation AXPERA Mildiou Essais Viticoles
BRIEF

published on 10/24/2025 at 18:05, 1 month 11 days ago

Amoéba Publie son Rapport Financier Semestriel

AMOEBA Biocontrôle Cosmétique Rapport Financier Amibes Brevetées
BRIEF

published on 10/24/2025 at 18:05, 1 month 11 days ago

Amoéba Publishes its Half-Yearly Financial Report

AMOEBA Financial Report Biocontrol Cosmetic Patented Amoebas
PRESS RELEASE

published on 10/24/2025 at 18:00, 1 month 11 days ago

Amoéba: Publication of the half-year financial report as of June 30, 2025
Amoéba announces the availability of its half-year financial report for the period ending June 30, 2025, filed with the French Financial Markets Authority. The report can be accessed on the company's website

AMOEBA French Financial Markets Authority Half-year Financial Report GreenTech Microbiological Solutions
PRESS RELEASE

published on 10/24/2025 at 18:00, 1 month 11 days ago

Amoéba : Mise à disposition du rapport financier semestriel au 30 juin 2025
Amoéba publie son rapport financier semestriel au 30 juin 2025 auprès de l'AMF. Greentech développant des solutions microbiologiques naturelles. Informations consultables sur leur site

AMOEBA AMF Rapport Financier GreenTech Microbiologique
BRIEF

published on 10/20/2025 at 18:35, 1 month 15 days ago

AXPERA primée pour son innovation en biocontrôle

AMOEBA Biocontrôle Innovation Environnement AXPERA
BRIEF

published on 10/20/2025 at 18:35, 1 month 15 days ago

AXPERA awarded for its innovation in biocontrol

AMOEBA Innovation Biocontrol Environment AXPERA

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 59 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 4 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 34 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 29 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 34 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 34 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 4 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 44 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 9 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 19 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:14, 13 hours 20 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 34 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 34 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 49 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 49 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE